Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial. Hansen, M. S, Wölfel, E. M, Jeromdesella, S., Møller, J. K, Ejersted, C., Jørgensen, N. R, Eastell, R., Hansen, S. G, & Frost, M. eClinicalMedicine, Elsevier, 2024.
bibtex   
@article{hansen2024once,
  title={Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial},
  author={Hansen, Morten S and W{\"o}lfel, Eva M and Jeromdesella, Shakespeare and M{\o}ller, Jens-Jakob K and Ejersted, Charlotte and J{\o}rgensen, Niklas R and Eastell, Richard and Hansen, Stinus G and Frost, Morten},
  journal={eClinicalMedicine},
  volume={72},
  year={2024},
  publisher={Elsevier}
}

Downloads: 0